115 related articles for article (PubMed ID: 3278878)
1. Bitolterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible obstructive airways disease.
Friedel HA; Brogden RN
Drugs; 1988 Jan; 35(1):22-41. PubMed ID: 3278878
[TBL] [Abstract][Full Text] [Related]
2. Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma.
Orgel HA; Kemp JP; Tinkelman DG; Webb DR
J Allergy Clin Immunol; 1985 Jan; 75(1 Pt 1):55-62. PubMed ID: 3968329
[TBL] [Abstract][Full Text] [Related]
3. Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.
Richards DM; Brogden RN
Drugs; 1985 Jul; 30(1):6-21. PubMed ID: 2863125
[TBL] [Abstract][Full Text] [Related]
4. Bitolterol mesylate aerosol in adults with steroid-dependent asthma: a comparison with isoproterenol hydrochloride aerosol.
Nathan RA; Bodman SF; Storms WW; Mingo TS
Ann Allergy; 1986 Jun; 56(6):494-9. PubMed ID: 3717716
[TBL] [Abstract][Full Text] [Related]
5. Concomitant bitolterol mesylate aerosol and theophylline for asthma therapy, with 24 hr electrocardiographic monitoring.
Kemp JP; Chervinsky P; Orgel HA; Meltzer EO; Noyes JH; Mingo TS
J Allergy Clin Immunol; 1984 Jan; 73(1 Pt 1):32-43. PubMed ID: 6693665
[TBL] [Abstract][Full Text] [Related]
6. Bitolterol mesylate: a beta-adrenergic agent. Chemistry, pharmacokinetics, pharmacodynamics, adverse effects and clinical efficacy in asthma.
Walker SB; Kradjan WA; Bierman CW
Pharmacotherapy; 1985; 5(3):127-37. PubMed ID: 3895171
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the bronchodilator effects of nebulized bitolterol mesylate and isoproterenol hydrochloride in steroid-dependent asthma.
Nathan RA; Bernstein IL; Bronsky EA; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Pinnas JL; Repsher LH
J Allergy Clin Immunol; 1987 May; 79(5):822-9. PubMed ID: 3571773
[TBL] [Abstract][Full Text] [Related]
8. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma.
Bartow RA; Brogden RN
Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248
[TBL] [Abstract][Full Text] [Related]
9. Studies on bitolterol, di-p-toluate ester of N-tert.-butylarterenol: a new long-acting bronchodilator with reduced cardiovascular effects.
Minatoya H
J Pharmacol Exp Ther; 1978 Sep; 206(3):515-27. PubMed ID: 702319
[TBL] [Abstract][Full Text] [Related]
10. Dose-response study of nebulized bitolterol mesylate solution in asthmatic patients.
Pinnas JL; Bhatt BD; Campbell SC; Kemp JP; Tinkelman DG
Chest; 1987 Apr; 91(4):533-9. PubMed ID: 3549173
[TBL] [Abstract][Full Text] [Related]
11. Formoterol. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.
Faulds D; Hollingshead LM; Goa KL
Drugs; 1991 Jul; 42(1):115-37. PubMed ID: 1718682
[TBL] [Abstract][Full Text] [Related]
12. Bitolterol compared to isoproterenol in advanced chronic obstructive pulmonary disease.
Petty TL; Scoggin CH; Rollins DR; Repsher LH
Chest; 1984 Sep; 86(3):404-8. PubMed ID: 6380974
[TBL] [Abstract][Full Text] [Related]
13. New beta 2-adrenergic agonist aerosols.
Kelly HW
Clin Pharm; 1985; 4(4):393-403. PubMed ID: 2864159
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
Sin DD; Man SF
Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
[TBL] [Abstract][Full Text] [Related]
15. Bitolterol mesylate in exercise-induced asthma.
Walker SB; Bierman CW; Pierson WE; Shapiro GG; Furukawa CT; Mingo TS
J Allergy Clin Immunol; 1986 Jan; 77(1 Pt 1):32-6. PubMed ID: 3944373
[TBL] [Abstract][Full Text] [Related]
16. Outpatient management of asthma with regular nebulized beta agonists: comparison of bitolterol mesylate and isoproterenol.
Kemp JP; Orgel HA; Grossman J; Reed CE; Tinkelman DG; Webb DR; Ziment I
Ann Allergy; 1987 Jul; 59(1):17-20. PubMed ID: 3300436
[TBL] [Abstract][Full Text] [Related]
17. Multicenter dose-ranging study of bitolterol mesylate solution for nebulization in children with asthma.
Nathan RA; Bronsky EA; Dockhorn RJ; Kemp JP
Ann Allergy; 1994 Mar; 72(3):209-16. PubMed ID: 8129213
[TBL] [Abstract][Full Text] [Related]
18. Bitolterol mesylate (WIN 32784) aerosol. A new long-acting bronchodilator with reduced chronotropic effects.
Kass I; Mingo TS
Chest; 1980 Aug; 78(2):283-7. PubMed ID: 6995040
[TBL] [Abstract][Full Text] [Related]
19. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
Jarvis B; Markham A
Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
[TBL] [Abstract][Full Text] [Related]
20. Effects of salbutamol and bitolterol mesilate on pO2 levels in asthmatic patients and healthy volunteers.
Dal Negro R; Cogo AL; Pomari C; Turati C; Turco P; Allegra L
Arzneimittelforschung; 1992 Jul; 42(7):959-61. PubMed ID: 1418062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
